EMA — authorised 19 September 2016
- Marketing authorisation holder: Allergan Pharmaceuticals International Limited
- Status: approved
🇪🇺 Viberzi in European Union
EMA authorised Viberzi on 19 September 2016
Marketing authorisations
EMA — authorised 19 September 2016
- Application: EMEA/H/C/004098
- Marketing authorisation holder: Allergan Pharmaceuticals International Limited
- Local brand name: Truberzi
- Indication: Truberzi is indicated in adults for the treatment of irritable bowel syndrome with diarrhoea (IBS D).
- Status: withdrawn
Viberzi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in European Union
Frequently asked questions
Is Viberzi approved in European Union?
Yes. EMA authorised it on 19 September 2016; EMA authorised it on 19 September 2016.
Who is the marketing authorisation holder for Viberzi in European Union?
Allergan Pharmaceuticals International Limited holds the EU marketing authorisation.